EC
Epidarex Capital
Micro VCActiveEpidarex invests in early-stage, high growth life science and health technology companies in under-ventured markets within the UK and them.
24
Investments
4
Exits
$250M
AUM
16.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Epidarex Capital.
Investment Thesis & Strategy
Epidarex Capital invests in early-stage, high-growth life science and health technology companies in the UK and North America, focusing on under-ventured markets. They invest across various stages.
Investment Activity
Deals per year over the last 8 years
1
20162
20171
20181
20190
20204
20211
20222
2023Portfolio Companies
Selected investments from their portfolio of 24 companies
E
EnteroBiotix
Biotech · Series A, 2023
I
InnoScot Health
Healthcare · Seed, 2023
M
Microplate Technologies
Healthcare · Seed, 2022
M
MitoRx Therapeutics
Biotech · Series A, 2021
E
Elasmogen
Biotech · Series A, 2021
M
MitoRx Therapeutics
Biotech · Series A, 2021
E
Elasmogen
Biotech · Series A, 2021
C
ClinSpec Dx
Biotech · Series A, 2019
E
Exonate
Biotech · Series A, 2018
B
BioSure
Healthcare · Series A, 2017
P
ProAxsis
Biotech · Series A, 2017
O
Optoscribe
Biotech · Series A, 2016
Notable Exits
CompanyTypeYearValue / Acquirer
FocalPointAcquisition2023—
EnteroBiotixAcquisition2023—
ExscientiaIPO2022$400M
ElasmogenAcquisition2022—
Frequently Asked Questions
Epidarex Capital focuses on Seed, Series A stage investments.
Related Investors
Cystic Fibrosis Foundation
Bethesda, United States · 19 deals
SV Angel
San Francisco, United States · 922 deals
Right Side Capital Management
San Francisco, United States · 894 deals
Kima Ventures
Paris, France · 565 deals
Alumni Ventures Group
Manchester, United States · 442 deals
FundersClub
San Francisco, United States · 425 deals